North America Exosome Therapeutic Market By Type (Natural Exosomes, Hybrid Exosomes), Source (Dendritic Cells, Mesenchymal Stem Cells, Blood, Milk, Body Fluids, Saliva, Urine Others), Therapy (Immunotherapy, Gene Therapy, Chemotherapy), Transporting Capacity (Bio Macromolecules, Small Molecules), Application (Oncology, Neurology, Metabolic Disorders, Cardiac Disorders, Blood Disorders, Inflammatory Disorders, Gynecology Disorders, Organ Transplantation, Others), Route of administration (Oral, Parenteral), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes), By Country (U.S., Mexico), Market Trends and Forecast to 2026
Market Analysis and Insights: North America Exosome Therapeutic Market
Exosome therapeutic market is expected to gain market growth in the forecast period of 2019 to 2026. Data Bridge Market Research analyses that the market is growing at a CAGR of 22.2% in the forecast period of 2019 to 2026 and expected to reach USD 16,979.73 million by 2026 from USD 3,398.20 million in 2018. Increasing prevalence of Lyme disease, chronic inflammation, autoimmune disease and other chronic degenerative diseases and increasing demand for anti-aging therapies are the factors for the market growth.
Exosomes are used to transfer RNA, DNA, and proteins to other cells in the body by making alteration in the function of the target cells. Increasing research activities in exosome therapeutic is augmenting the market growth as demand for exosome therapeutic has increased among healthcare professionals.
Rising research activities on exosomes for the treatment of various diseases such as skin, cancer and others to enhance the market growth. For instance, In August, Evox Therapeutics has received patents grant by the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) for three key patents which includes exosome-mediated RNA therapeutics and targeted exosome drug delivery. The patent grant will help company to increase revenue generation in the future.
This exosome therapeutic market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Exosome Therapeutic Market Scope and Market Size
North America exosome therapeutic market is segmented of the basis of type, source, therapy, transporting capacity, application, route of administration and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Based on type, the market is segmented into natural exosomes and hybrid exosomes. Natural exosomes are dominating in the market because natural exosomes less harmful compare than hybrid exosomes as well as rising cases of chronic disease increase demand of better alternative treatment. For instance In August 2019, Evox Therapeutics has received patents grant by the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) for three key patents which includes exosome-mediated RNA therapeutics and targeted exosome drug delivery. The Patent grant will help company to increase revenue generation in the future.
Based on source, the market is segmented into dendritic cells, mesenchymal stem cells, blood, milk, body fluids, saliva, urine and others. Mesenchymal stem cells are dominating in the market because they are widely used in clinical trial study for various diseases in the U.S as well as Mesenchymal stem cells have gained popularity in the field of regenerative medicines due to their better safety profile in human patients and recently confirmed efficacy in late-stage clinical studies.
Based on therapy, the market is segmented into immunotherapy, gene therapy and chemotherapy. Chemotherapy segment is dominating in the market because rising case of cancers in the North America and chemotherapy as a primary treatment to destroy cancer cells, As per the American Cancer Society 63.00% patients treated with chemotherapy in the U.S.
Based on transporting capacity, the market is segmented into bio macromolecules and small molecules. Bio macromolecules are dominating in the market because bio macromolecules such as RNA, lipids and proteins. The structure of extracellular vesicles changes in pathological and physiological conditions as well as play important role in repair and regeneration. So it is used rising for therapeutic purpose.
Based on application, the market is segmented into oncology, neurology, metabolic disorders, cardiac disorders, blood disorders, inflammatory disorders, gynaecology disorders, organ transplantation and others. Oncology is dominating in the market because rising cases of oncology disease in the North America. As per the American Cancer Society in 2019, around 228,150 news cases of lung cancers raised in the U.S.
Based on route of administration, the market is segmented into oral and parenteral. Parenteral route of administration is dominating in the market due to drug is directly supplied in the blood, better bioavailability and reliable dose.
Based on end user, the market is segmented into hospitals, diagnostic centres and research & academic institutes and others. Hospital is dominating in the market because hospitals provide better treatment facilities and availability of medical staffs. As per the American Hospitals Association, in 2017, around 6200 active hospitals in the U.S
Exosome Therapeutic Market Country Level Analysis
The North America market is analysed and market size information is provided by country by type, source, therapy, transporting capacity, application, route of administration, end user.
The countries covered in the exosome therapeutic market report are U.S., Mexico in North America.
North America exosome therapeutics market is growing due to rising cases of disease such as cancers; skin disease is expected to grow at the significant growth rate in the forecast period of 2190 to 2026 because of rising awareness about the advance treatment alternatives. For instance In the United States, as per the National Cancer Institute report of 2018, an estimated 1.7 million new cases of cancer were diagnosed in the country and nearly 0.6 million patients died due to cancer.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strong Investment in Research and Development Activities and New Technology Penetration
North America exosome therapeutics market also provides you with detailed market analysis for every country growth in availability base of different products for exosomes therapeutics market, impact of technology using line curves and changes in medical regulatory scenarios and their impact on exosomes therapeutics market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Exosome Therapeutics Market Share Analysis
North America exosome therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America electric vehicle market.
The major players covered in the report are Stem Cells Group, Aegle Therpeutics, Avalon Globocare Corp, Boehringer Ingelheim International GMBH, Capricor Therapeutics , Codiak Biosciences, Creative Medical Technology Holdings, INC., Jazz Pharmaceuticals, INC., Reneuron Group PLC, United Therapeutics Corporation, among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
- In January 2019, Jazz Pharmaceuticals, Inc. has collaborated with Codiak BioSciences to develop and commercialize exosome therapeutics to treat cancer. The collaboration will help the company to address issues which have been often implicated in solid tumors and hematological malignancies.
- In May 2018, Creative Medical Technology Holdings, Inc. has filed patent for AmnioStem stem cells to use it for reducing/reversing natural aging. The patent will help the company to recapitulate effect in technically and an ethical feasible manner and to generate revenue in future as usage of young blood in stimulation of regeneration in aged patients which was gaining attention in the area of regenerative medicine.
Partnership, collaboration and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for electric vehicles through expanded model range
Customization Available : North America Exosome Therapeutic Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.